Intuitive Surgical, Inc. (NASDAQ:ISRG) Stake Raised by IPG Investment Advisors LLC

IPG Investment Advisors LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,771 shares of the medical equipment provider’s stock after purchasing an additional 376 shares during the period. IPG Investment Advisors LLC’s holdings in Intuitive Surgical were worth $1,446,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently made changes to their positions in ISRG. RWA Wealth Partners LLC lifted its stake in Intuitive Surgical by 0.3% during the fourth quarter. RWA Wealth Partners LLC now owns 7,643 shares of the medical equipment provider’s stock valued at $3,989,000 after purchasing an additional 21 shares during the last quarter. Summit Securities Group LLC bought a new position in shares of Intuitive Surgical in the fourth quarter valued at $30,000. Schroder Investment Management Group lifted its position in shares of Intuitive Surgical by 5.9% during the 4th quarter. Schroder Investment Management Group now owns 420,798 shares of the medical equipment provider’s stock valued at $219,640,000 after acquiring an additional 23,426 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its stake in shares of Intuitive Surgical by 11.1% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 369,968 shares of the medical equipment provider’s stock worth $193,108,000 after acquiring an additional 37,063 shares in the last quarter. Finally, Allianz SE bought a new stake in shares of Intuitive Surgical during the 4th quarter worth $1,698,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In other news, EVP Brian Edward Miller sold 8,900 shares of the company’s stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now owns 5,758 shares in the company, valued at approximately $2,793,033.06. This represents a 60.72 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 33,754 shares of company stock worth $17,691,621. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $491.84 on Friday. The firm has a market cap of $175.18 billion, a PE ratio of 76.73, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The firm’s 50 day moving average price is $556.28 and its 200 day moving average price is $532.68.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several analyst reports. Jefferies Financial Group upped their target price on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Robert W. Baird reduced their price objective on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a research note on Tuesday, March 18th. Truist Financial dropped their target price on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating on the stock in a research report on Monday, March 17th. Bernstein Bank upped their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. Finally, Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.